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ABSTRACI  The membrane-damaging  C5b-9(m)  complex of complement  is a cylindrically structured, 
amphiphilic  molecule  that is generated  on  a target  membrane  during complement  attack.  Isolated 
C5b-9(m)  complexes are shown here to possess the capacity of binding a protein, termed "S"-protein, 
that  is present  in  human  plasma. Binding of  this  protein  apparently  shields  the apolar  surfaces  of 
C5b-9(m),  since  the  resulting  "SCSb-9(m)"  complex  is  hydrophilic  and  no  longer  aggregates  in 
detergentfree solution. Dispersed SC5b-9(m) complexes exhibit an apparent sedimentation coefficient 
of 29S in sucrose density gradients, corresponding to a molecular  weight of ~1.4 million.  SDS PAGE 
analyses indicate binding of 3-4 molecules  S-protein per CSb-9(m)  complex. These data are consistent 
with a monomer  nature and molecular weight of 1-1.1 million of the CSb-9(m)  complex. Ultrastruc- 
tural  analysis of SC5b-9(m)  shows preservation of the hollow cylindrical  C5b-9(m)  structure. Addi- 
tional material,  probably representing the S-protein itself, can be visualized attached to the originally 
membrane-embedded  portion of the macromolecule.  The topography of apolar surfaces on a molecule 
thus appears directly probed and visualized through the binding of a serum  protein. 
Complement-mediated  membrane  damage  is  caused  by the 
attachment of the terminal C5b-9 complement components to 
the target lipid  bilayer (17,  19,  26).  These proteins assemble 
into a macromolecular C5b-9(m) protein complex which pos- 
sesses  the  structure  of a  hollow  cylinder  that  lies  partially 
embedded  within  the  membrane,  probably creating  a  trans- 
membrane  channel  (4,  18,  20,  27).  The  complex  has  been 
shown to be an amphiphilic molecule with properties typical 
of an integral membrane protein (12, 25): it is not eluted from 
the membranes by ionic manipulations (1,  13); it is solubilized 
by Triton X-100 (2, 29); it binds large amounts of detergent (3, 
10), and also binds lipid (4, 7) to become reincorporated into 
artificial lipid vesicles.  The formation of C5b-9(m) is unique in 
that it represents  the only known case of such a transition of 
serum proteins from a hydrophilic to an amphiphilic state. 
Complement activation can also occur in the absence of a 
target  lipid  bilayer,  e.g.,  via  the  alternative  pathway  when 
particulate inulin is added to serum (14,  15). In these cases, a 
macromolecular complex consisting of C5b-C9(m) components 
forms in solution. However, another serum protein, termed the 
"S-protein"  becomes additionally  incorporated (16).  The en- 
suing  macromolecule, accordingly designated  "SC5b-9",  is a 
water-soluble,  noncytolytic protein  of 1,000,000  mol wt with 
no  currently  known  biological  function.  Evidence  indicates 
that the S-protein binds to the nascent terminal complex at the 
stage of C5b-7 assembly, whereby it is believed to bind to and 
mask  apolar  surfaces,  thus  abrogating  the  capacity  of the 
trimolecular  complex to hydrophobically interact  with  lipid 
bilayers (22).  Compatible  with  this  view  is  the  finding  that 
removal of the S-protein from SC5b-9 through high concentra- 
tions of deoxycholate (23) or by tryptic attack (5, 23) leads to 
exposure of lipid-binding surfaces on the macromolecule. 
In the present study, we show that the S-protein can bind to 
preformed,  C5b-9(m) complexes and hereby convert the pri- 
marily amphiphilic macromolecule to a hydrophilic state.  U1- 
trastructural analyses locate the binding sites for the S-protein 
to the outer surface of the C5b-9(m) complex, and are consist- 
ent with previous conclusions regarding the topography of the 
apolar region on the protein cylinder (4, 6, 27). Hydrodynamic 
analyses  indicate  a  molecular  weight  of 1.4  million  for the 
SC5b-9(m) complex, supporting the contention that the C5b- 
9(m) complex is a  monomer entity (19),  rather than  a dimer 
complex (11) of the C5b-9(m) components. 
MATERIALS  AND  METHODS 
Preparation  of C5b-9(m) 
Rabbit erythrocytes  drawn in 10 mM EDTA (final concentration) were washed 
three times in saline.  One volume of a  I0% cell suspension in veronal-buffered 
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©  The Rockefeller  University Press  . 0021-9525/B2/09/0755/05  $1.00  755 saline containing 1.0 mM  Mg  2+ and 0.15 mM  Ca  2+ was lysed at 37°C by the 
addition of l vol whole human serum (WHS). Lysis occurring through alternative 
complement activation (21 ) was complete within 3 min. Membranes were pelleted 
(Sorvall GSA rotor, 10,000 rpm, 15 min at 4°C: Du Pont Instruments, Newtown, 
CT)  and washed three times in  5  mM  sodium phosphate buffer, pH  8.0. The 
washed membranes were solubilized by the addition of solid sodium deoxycholate 
(Merck &  Co., Inc., Rahway, NY, analytical grade) to a  final concentration of 
10% (wt/vol) (250 mM) and agitation at room temperature for 15-30 min (I 1). 
Aliquots of 3 ml of solubilized membrane material were applied to 36-ml, linear 
10-50% sucrose density gradients prepared in 5 mM Tris-HCL 25 mM  NaCI, 
pH  8.2, containing 4  mM  deoxycholate. The  gradients were centrifuged in a 
Beckmann vertical rotor (type VTi-50 Beckmann Instruments, Fullerton, CA) 
for 3 h at 45,000 rpm, 4°C. 20 equal fractions were collected from the bottom of 
the tubes. Those containing the C5b-9(m) peak (fractions 3-8, corresponding to 
26-38S) were pooled and used in further experiments. 
Binding of Serum S-Protein  to CSb-9(m)  and 
Isolation of SCSb-9(m) 
WHS  was  used  as  the  source  of S-protein.  35-ml  aliquots of WHS  were 
chromatographed over Sepharose 6B (4 x  90 cm) in 50 mM Tris, 100 mM NaCI, 
15 mM  NaN:~, pH 8.2. Flow rates were 30~0 ml/h and  18 to 20-ml fractions 
were collected at 4°C. Aliquots of fractions from the column were assayed by 
fused rocket immunoelectrophoresis with  the use of specific antibodies to a2- 
macroglobulin and C3 complement component (obtained from Dakopatts Im- 
munoglobulin A/S, Copenhagen, Denmark). These two protein moieties were 
cleanly separated from each other by the Sepharose chromatography. Fractions 
commencing from the void volume and extending to cover the entire ct~-macro- 
globulin peak were discarded. All  fractions from the  C3  peak onwards were 
pooled,  ending with  the  column  bed  volume,  and  concentrated to  20-30 ml 
(Amicon PM  10 membrane: Amicon Corp., Lexington, MA). The concentrated 
protein solution was then added to solutions of C5b-9(m) at a  volume ratio of 
1:1. The samples were dialyzed against 50 vol of isotonic saline/10 mM EDTA, 
pH 8.0 at 4°C for 18 h. In later experiments, EDTA was omitted with no change 
in  the  results.  Thereafter,  the  samples  were  concentrated  to  ~8-9  ml  and 
chromatographed over a  2- x 90-cm Sepharose 6B column in the buffer stated 
above. Fractions containing the SC5b-9(m) complex, initially identified by an 
antiserum to C5b-9(m), were pooled, concentrated to 0.5-0.8 ml and applied to 
a  12-ml 10-43% (wt/wt) linear sucrose density gradient containing no detergent. 
Centrifugation was in an SW 41 Ti rotor (Beckmann Instruments) for 16 h  at 
35,000 rpm, and 4°C. 20 equal fractions were collected from the bottom of the 
tubes. SC5b-9(m) complex was recovered in fractions 2-8 corresponding to 26- 
40S, and analysed by SDS PAGE, immunoelectrophoresis, and in the electron 
microscope. 
Estimation  of Sedimentation Coefficient and 
Molecular Radius of SC5b-9(m) 
Individual fractions containing SC5b-9(m) recovered from the sucrose density 
gradient were dialyzed to remove sucrose, concentrated to 0.3 ml by packing the 
dialyzed  bags in  Sephadex  G-100,  and  then  recentrifuged  on  linear  sucrose 
density gradients. Sedimentation coefficients were estimated from the sediment- 
ing positions of the proteins, using serum transferrin (5.5S), IgG (7S), C3 (9.5S), 
lgM  (19S), and SC5b-9 (22,5S) as standards, as detailed in reference  10. The 
protein recovered after these sedimentation analyses was then cbromatographed 
over Sepharose 6B  (1  x  60 cm) and the eluting position compared to that of 
SC5b-9 (molecular radius: -I 1 nm) and lgM (molecular radius: ~12 nm) on the 
same column. 
Electroimmunoassay 
Rocket and fused rocket immunoelectrophoresis were performed in 1% agarose 
gels as previously described (1, 27). In specified cases, 0,5% (vol/vol) Triton X- 
100 was present in the agarose. Electrophoreses were run overnight at 2-3 V/cm. 
SDS PAGE 
Protein samples were made 2% in SDS and briefly boiled (5 s). A discontinuous 
slab gel electrophoresis system was used as in reference 8. Running and stacking 
gels were 10% and 5% acrylamide, respectively: both contained 6.4 M urea. Gels 
were stained with Coomassie Brilliant Blue. 
Electron Microscopy 
Negative stainings were performed as given in  reference 27,  using sodium 
silicotungstate at pH 8.2 or sodium phosphotungstate at pH 6.8 with identical 
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results. Sucrose was removed by dialysis before staining. Specimens were exam- 
ined at 80 kV in a JEOL I00 CS electron microscope equipped with an ultra high 
resolution objective lens pole piece (Cs ~0.7) using apertures of 200 ttm in the 
condensor and 40 or 60/xm in the objective. Micrographs were recorded at 50- 
90,000 times magnification by standard or low dose exposure techniques. 
RESULTS 
Fig. l depicts a fused rocket immunoelectrophoresis of fractions 
recovered  from  a  sucrose  density  gradient  centrifugation  of 
DOC-solubilized, complement-treated erythrocyte membranes. 
The  C5b-9(m)  complex  (arrow,  Fig.  1A),  identifiable  with  a 
specific antiserum (Fig.  1 B) sediments in a broad peak cover- 
ing  a  region  of 25-40S.  The  high  molecular  weight  material 
represents  oligomeric  aggregates  of  the  complex;  monodis- 
persed C5b-9(m) cylinders are found at a region corresponding 
to 26-29S  in  this system  (reference  10  and  Fig.  4).  The  SDS 
PAGE  pattern of C5b-9(m)  as recovered from such a gradient 
is shown below (Fig.  3, gel a). 
The rationale of the present experiments was to take isolated 
C5b-9(m)  complexes,  bind  the  S-protein  from  serum,  and 
reisolate the ensuing SC5b-9(m) complexes. Earlier studies had 
indicated the molecular weight of the S-protein or its smallest 
FIGURE  1  Isolation  of 
human  CSb-9(m)  from 
target  rabbit  erythro- 
cyte  membranes.  The 
membranes  were  solu- 
bilized  in  250  mM  de- 
oxycholate and applied 
to  linear  10-50%  (wt/ 
vol)  sucrose  density 
gradients  containing 
6.25 mM  deoxycholate. 
Centrifugation was in a 
preparative vertical  ro- 
tor as detailed in Mate- 
rials  and  Methods. 
Twenty equal  fractions 
were collected and  ali- 
quots  were  applied  in 
fused  rocket  immuno- 
electrophoresis  using 
polyspecific  antibodies 
to  human  serum  pro- 
teins  (A)  and  specific 
anti-C5b-9(m)  antise- 
rum  (B)  in Triton-con- 
taining  agarose  gels. 
The C5b-9(m)  complex 
sedimented  in  a  broad 
region covering 25-40S, 
with  a  protein  peak at 
29S  (arrows,  A),  and 
was separated from the 
bulk  of  other  serum 
proteins.  Erythrocyte 
membrane  proteins 
were not identified  im- 
munochemically,  but 
were  found  by  SDS 
PAGE analyses to be lo- 
cated  virtually  quanti- 
tatively in the later gradient fractions (fraction 9 onward, results not 
shown).  Closed circles denote the fractions that were pooled and 
used  as starting material for the SC5b-9(m)  preparation. The poly- 
peptide gel  electrophoresis  pattern  of  C5b-9(m)  thus  obtained  is 
shown in Fig. 3, gel a. subunit to be -88,000, as determined by SDS PAGE (16).  By 
densitometry,  three  molecules of the  88,000-dalton  S-protein 
(or subunit)  appeared  to become bound to each molecule of 
C5b-9  during  formation  of the  fluid-phase  SC5b-9 complex 
(16).  Thus,  the  maximal  molecular  weight  of the  native  S- 
protein  could be assumed not to exceed 265,000 (in the case 
that  the  native  protein  consisted  of a  noncovalently  linked 
trimer  of the  88,000-mol wt  subunit).  The experimental  ap- 
proach  for  isolation  of  SC5b-9(m)  took  advantage  of  the 
marked  difference  in  size  between  the  membrane  C5b-9(m) 
complex  and  the  native  S-protein.  Human  serum  was  first 
depleted  of protein  that  eluted  on  Sepharose  ahead  of C3 
(200,000  mol wt).  When C5b-9(m)  in detergent  solution was 
added to the low molecular weight serum protein pool (con- 
taining S-protein) and the detergent was removed by dialysis, 
rechromatography immediately permitted recovery of the ter- 
minal  complex  in  highly  purified  form  (Fig.  2).  A  single 
centrifugation  in  a  sucrose  density  gradient  resulted  in  the 
recovery of the terminal complex virtually free of contaminants 
(Fig. 2 B). The protein was distributed over a somewhat broad 
region in the gradient, correponding to 26-40S, with the peak 
concentration at 28-30S.  Recentrifugation of individual  frac- 
tions from the gradient showed that this distribution was due 
to the presence of discrete, heterogeneous protein populations, 
each sedimenting true to its  given position in the repeat gra- 
dient  (results  not  shown).  In  no  case  did  higher  molecular 
sized-aggregates  form,  i.e.  the  protein  did  not  aggregate  in 
detergent-free solution. 
In contrast, C5b-9(m) self-associated extensively in the ab- 
sence  of detergent  to  form  large  molecular  aggregates  that 
sedimented to the bottom of the detergent-free sucrose density 
gradients (not shown). 
SDS PAGE of each  fraction from these  gradients  showed 
the presence of C5b-C9 plus the S-protein in fractions 2-8 (40- 
26S).  There were no conspicuous differences among the elec- 
trophoretograms  from the  individual  fractions.  Fig.  3  shows 
the subunit pattern of C5b-9(m) that was used as the starting 
material (gel a), and of the SC5b-9(m) complex recovered from 
the sucrose density gradient of Fig. 2 B (gel b). As reference for 
the migrational position of the S-protein, the pattern of fluid- 
phase SC5b-9 is shown (gel c). By densitometry, there are 3-4 
molecules of S-protein per molecule of C6 in both SC5b-9 and 
SC5b-9(m). It should be noted that apart from the difference 
in content of S-protein, human C5b-9(m) differs from SC5b-9 
in that it  contains  additional  C9 molecules that  are possibly 
present  as disulfide-linked  dimers (designated  C92 in Fig.  3) 
(see reference 28). 
Electron microscopical analyses of  C5b-9(m) and SC5b-9(m) 
are  shown  in  Fig.  4.  Dispersed  C5b-9(m)  in  deoxycholate 
solution exhibited  apparent sedimentation  coefficients of 26- 
29S and presented a hollow cylindrical structure as previously 
reported  (Fig.  4A).  Analysis  of the  individual  SC5b-9(m) 
fractions from the sucrose density gradients showed that cylin- 
drical  monomers were  present  in  fractions corresponding to 
28-29S (Fig. 4 B). In earlier fractions from the gradient, dimers 
and uninterpretable aggregates were found (Fig. 4 C). 
The basic structure of the C5b-9(m) complex, being a thin- 
walled cylinder rimmed by an annulus at one end (Fig. 4 D), 
was unaffected by the  binding  of S-protein.  However,  addi- 
tional  material,  appearing  as  a  girdle  at  the  middle  of the 
cylinder, was consistently identified on SC5b-9(m) complexes 
(Fig. 4 E). By inference, this material is interpreted to represent 
FIGURE  2  A:CSb-9(m)  recovered from the sucrose density gradient was added to EDTA-human serum that had been depleted of 
high molecular weight proteins (detailed in Materials and Methods). After removal of deoxycholate by dialysis, the protein sample 
was chromatographed over Sepharose 6B without detergent. The SC5b-9(m)  complex was then recovered in early fractions from 
the column,  (arrows), separated from the bulk of other serum proteins. Aliquots of the fractions from the column were analyzed 
by fused  rocket immunoelectrophoresis developed with  polyspecific antibodies to human plasma proteins. Closed circles denote 
the  fractions  that  were  pooled  for  subsequent  sucrose  density  gradient  centrifugation.  B  and  C:  Sucrose  density  gradient 
centrifugation  of  pooled  fractions  containing  the  SC5b-9(m)  complex  in  the  absence  of  detergent:  analysis  of  the  recovered 
fractions  by fused  rocket immunoelectrophoresis with the use of polyspecific antibodies to serum proteins (B)  and specific anti- 
CSb-9(m)  (C). The SCgb-9(m)  complex was recovered as a major protein peak at 29S (arrow,  B)  in highly purified form. 
RAPID COMMUNICATIONS  757 FIGURE  3  SDS  PAGE of C5b-9(m)  (gel a)  and SC5b-9(m)  (gel  b); 
the protein samples were taken from the sucrose density gradients 
of  Fig.  1  and  2,  respectively.  The  individual  bands  have  been 
designated according to their previous identification (references 9, 
28, 29). In addition to the normal banding pattern of C5b-9(m),  the 
SC5b-9(m) complex exhibits an  additional polypeptide band  (3-4 
moles per complex) corresponding to the S-protein. The polypeptide 
composition of fluid-phase SC5b-9(m) is shown in gel c as a refer- 
ence pattern for the S-protein. Note the presence of C9-dimer in 
C5b-9(m)  and SC5b-9(m),  but not in the SC5b-9(m) complex that 
primarily forms in the fluid-phase (see reference 28). 
the bound S-protein. Whether the distribution of this material 
was  truly rotationally symmetrical could  not  be  determined 
because of shielding by the  annulus in axial projections. On 
cylinders  seen  in  clean,  side  profile,  the  boundary  of  the 
attached  material towards  the  annulus  was  sharp,  while  its 
contour towards the originally membrane-embedded terminus 
of the cylinder was often blurred, probably indicating extension 
of material in this direction. 
The 29S material was chromatographed over Sepharose 6B 
and the protein was found to elute in a  region corresponding 
to that of IgM. From an assumed molecular radius of 12 nm, 
a sedimentation coefficient of 29S, and a partial specific volume 
of 0.72,  a  molecular weight of -  1.4 million was calculated for 
the SC5b-9(m) cylinder. This value is in good agreement with 
a C5b-9(m) molecular weight of 1-1.1 million, plus 3-4 mole- 
cules S-protein (260-350,000 daltons) per complex. 
DISCUSSION 
This study documents a singular case of an amphiphilic-hydro- 
philic molecular transition through binding of a serum protein 
to an amphiphilic protein complex. The serum S-protein that 
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is responsible for this effect has earlier been implicated as an 
inactivator/inhibitor of nascent  C5b-7  when  the  complex  is 
generated in serum away from a  target lipid bilayer (22, 23). 
The present data support this concept since they provide direct 
evidence for binding of the S-protein to hydrophobic surfaces 
on preformed, amphiphilic C5b-9(m) complexes. In the elec- 
tron microscope, the S-protein then appears to be attached to 
the originally membrane-embedded portion of the  C5b-9(m) 
cylinder. The collective results are fully compatible with the 
previously proposed C5b-9(m) model, which locates the apolar 
surfaces  on  the  molecule  to  the  thin-walled portion  of the 
cylinder that is situated opposite the annulus (4, 6, 27). 
Preparations  of detergent-solubilized C5b-9(m)  complexes 
exhibit some structural heterogeneity, although their purity by 
bioimmunochemical criteria is high. This may relate to a true 
heterogeneity of configuration arising during assembly of the 
complex, or it may be induced during the isolation procedure. 
Thus,  "opened"  rings (Fig. 4A  and  B) are quite frequent  in 
some preparations of solubilized C5b-9(m) or SC5b-9(m), but 
these are hardly found on fresh, complement-lysed membranes. 
We consider the closed cylindrical structure, which is identical 
with the principle membrane lesion identified on target mem- 
branes,  to  be  the  primarily relevant  structure  in  detergent- 
solubilized material. 
Hydrodynamic analyses of SC5b-9(m)  become possible in 
the absence of detergent and are consistent with a  monomer 
nature of the complex. Dispersed C5b-9(m) complexes in de- 
tergent solution exhibit an apparent sedimentation coefficient 
of 26-29S  and  a  protein molecular weight  of  1-1.1  million. 
Each C5b-9(m) complex can bind 3-4 molecules S-protein, and 
the  molecular weight of the  resulting SC5b-9(m)  complex is 
1.4 million. It should be noted that binding of the S-protein 
will not disrupt preexisting oligomeric aggregates of C5b-9(m). 
Therefore, it is necessary to ascertain by electron microscopy 
that the hydrodynamic data used for calculation of molecular 
weight apply to monodispersed protein. Since this and a  pre- 
vious study have shown that protein sedimenting at positions 
>30S (e.g. 33S as reported in references 11  and 24) is present 
as heterogeneous aggregates, claims to have proven a  dimeric 
composition of C5b-9(m) based on biochemical analysis of 33S 
fractions (24) also cannot be accepted as valid. Indeed, if each 
C5b-9(m)  cylinder were  to represent a  dimer composed of 2 
molecules C5b-C8, and 12 molecules C9, the molecular weight 
of the complex would be 2 million, and that of SC5b-9(m) 2.5- 
2.7  million. Clearly, this value is not compatible with a  sedi- 
mentation coefficient of 29S, or even 33-34S.  In this connec- 
tion,  it  is  noteworthy  that  the  lower  molecular  weight  (1 
million) and sedimentation coefficient (23S) of SC5b-9 formed 
primarily in  the  fluid-phase may  well  be  due  to  the  lower 
number of C9 molecules present per complex (2-3 instead of 
6), as has been recognized recently (28). 
Nomenclature 
To  distinguish among  the  different forms  of the  terminal 
complement complexes, we propose that the term "C5b-9(m)" 
rather  than  "MAC"  (11)  be  used  to  denote  the  membrane 
complex, and "SC5b-9" be used to designate the cytolytically 
inactive complex that forms in serum in the absence of a target 
membrane. The term "SC5b-9(m)" then adequately describes 
the  membrane  C5b-9(m)  complex  to  which  S-protein  has 
bound, as reported in this study. 
We  thank  Marion Muhly  and  Margit  Roth  for excellent  technical 
assistance. FIGURE  4  Panels A  and /3. Survey of 29S fractions of detergent solubilized C5b-9(m) complexes ( A ) and SC5b-9(m) complexes in 
detergent free solution (B). The majority of protein is present as cylindrically structured monomer entities. Some complexes seen 
in axial projections appear as opened rings in both preparations. Panel  C  Survey of a 33S fraction of SC5b-9(m) complexes. Most 
of the material appear as heterogeneous aggregates. Some complexes are seen as "twinned" rings (arrows). Panels  D  and f. C5b- 
9(m)  complexes (D)  and  SC5b-9(m)  complexes (E)  seen  in  side projections at  high  magnification.  The basic structure  of  the 
molecule is that of a thinwalled cylinder rimmed by an annulus at one end. SC5b-9(m)  complexes carry an additional "girdle" of 
material  (arrows  in  panel  E),  which  is  interpreted  to  represent  the  S-protein.  Sodium  silicotungstate  negative  staining.  All 
micrograph5, except left four flames of panel D, were recorded with  low electron exposure technique. Bars, 50 nm. 
This  study  was  supported  by  the  Deutsche  Forschungsgemeinschaft 
(grant  We  340/10). 
Received  for publication  15 April 1982,  and in revised  form  25 May  1982. 
REFERENCES 
I.  Bhakdi,  S.,  O.  J.  Bjerrum.  U.  Rother,  H  Kntiffermann,  and  D.  F.  H  Wallach.  1975. 
Immunochemicat  analyses  of membrane-bound  complement:  detection  of the terminal 
complement  complex  and  its  similarity  to  "intrinsic"  erythrocyte  membrane  proteins. 
Biochim  Biophrs. Acta. 406:21-25. 
2.  BhakdL  S.,  P  Ey.  and  B.  Bhakdi-Lehnen.  1976.  Isolation  of the  terminal  complement 
complex  from target sheep erythrocyte  membranes.  Biochim. Biophys. Acla. 413:445-456. 
3.  Bhakdi. S., O. J. Bjerrum, B. Bhakdi-Lehnen, and J. Tranum-Jensen.  1978. Complement 
tysis:  evidence  for an  amphiphilic  nature  of the terminal membrane  C5b-9 complex  of 
human complement. J. ImmunoL  121:2526-2532 
4.  BhakdL S,. and J, Tranum-Jensen.  1978, Molecular nature of the complement lesion. Proc. 
Natl. Acad. ScL  U  S. A. 75:5655-5659, 
5.  Bhakdi. S. B  Bhakdi-Lehnen, and J. Tranum-Jensen.  1979. Proteolytic transformation of 
SC5b-9  into  an  amphiphilic  macromolecule  resembling  the  C5b-9  membrane  attack 
complex of complement,  lmmunologF,  37:901-912. 
6.  Bhakdi. S., J. Tranum-Jensen.  1979.  Evidence for a two-domain structure of the terminal 
membrane C5b-9 complex of human compleme0.t, Proc. NatL A cad Sci. U. S. A, 76:5872- 
5876. 
7.  Bhakdi, S.. and J, Tranum-Jensen  1980. Re-incorporation of the terminal C5b-9 comple- 
ment  complex  into  lipid  bilayers:  formation  and  stability  of reconstituted  liposomes. 
Immunology,  41:737-742. 
g  Bhakdi,  S.,  J.  Tranum-Jensen,  and  O.  Klump.  1980.  The  terminal  membrane  C5b-9 
complex of human complement.  Evidence for the existence of multiple protease-resistant 
polypeptides  that form the trans-membrane  complement channel..L  lmmunoL  124:2451 
2457. 
9.  Bhakdi,  S.,  and  M.  Roth,  1981.  Fluid-phase  SC5b-8  complex  of human  complement: 
generation and isolation from serum. J. lmmunoL  I27:576  580. 
10  Bhakdi,  S.,  and  J.  Tranum-Jensen.  1981.  Molecular  weight  of the  membrane  C5b-9 
complex  of human  complement:  characterization  of the  terminal  complex  as  a  C5b-9 
monomer.  Proc. NatL Acad  Sci. U. S. A. 78:1818-1822. 
1 I.  Biesecker, G.,  E  R.  Podack,  C.  A.  Halverson,  and  H. J.  Miiller-Eberhard  1979.  C5b-9 
dimer; isolation from complement-lysed  cells and  ultrastructural identification with com- 
plement-dependent  membrane lesions ,L Exp.  Med.  149:448-459. 
12.  Bretscher, M. S., and  M. C.  Raff.  t975  Mammalian  plasma membranes.  Nature (LoncL). 
258:43-49. 
13.  Hammer, C. H., A. Nicho[son, and M, M. Mayer. 1975. On the mechanism of cytolysis by 
complement: evidence on insertion of C5b and C7 subunits of the C5b, 6, 7 complex into 
the phospholipid  bilayer of erythrocyte membranes.  Proc. Natk  Acad Acad ScL  U. S. A. 
72:5076-5079, 
14,  Kolb,  W.  P.,  J. A  Haxby, C. M. Arroyave, and  H. J. MiJller-Eberhard.  1972.  Molecular 
analysis of the membrane attack mechanism  of complement. J. Exp.  Med.  135:549-566. 
15  Kolb,  W,  P.,  and  H.  J.  Muller-Eberhard.  1973.  The  membrane  attack  mechanism  of 
complement.  Verification  of a  stable  C5-C9  complex  in  free  solution.  £  Exp.  Med. 
138:43845 I. 
16.  Kolb.  W.  P..  and  J.  J.  Mtiller-Eberhard  1975.  The  membrane  attack  mechanism  of 
complement.  Isolation  and  subun,~t  composition  of the  C5b-9  complex,  d.  Exp.  Mad. 
141:724-  725. 
17  Lachmann.  P.  J.  and  R,  A.  Thompson.  1970.  Reactive  lysis: the complement-mediated 
lysis of unsensitized  cells.  I1. The characterization  of activated  reactor as C5b  and  the 
participation of C8 and C9. J. Exp. Med.  131:644-657. 
18.  Mayer. M  M.  1972.  Mechanism of cytolysis by complement.  Proc Natl dcad Acad Sci. 
U. S. A. 69:2954 2959. 
19  Mayer, M. M  1978. Complement,  past and present, ltarv(t'  Lect. 72:139  175 
20.  Michaels,  D. W., A. S.  Abramovitz,  C  H.  Hammer,  and  M. M, Mayer.  1976.  Increased 
ion  permeability  of  planar  lipid  bilayer  membranes  after  treatment  with  the  C5b-9- 
cytoiytic  attack  mechanism  of  complement.  Proc. NatL Acad  Acad  Sci  U.  S.  A. 
73:2852-2856. 
21.  Piatt-Mills. T. A. E.. av.d K. ishizaku. 1974. Activation of the alternate pathway of human 
complement  by rabbit cells..L lmmunoL  113:348  358. 
22  Podack. E. R. and  H. J, Miiller-Eberhard. 1978.  Binding of deoxycholate,  phosphatidyl- 
choline vesicles, lipoprotein, and  of the S-protein to complexes of terminal complement 
components.  J. ImmunoL  121 :  1025-1038. 
23  Podack,  E.  R..  and  H.  J.  Miiller-Eberhard.  1980.  SC5b-9  complex  of complement: 
formation of the dimeric membrane attack complex by remvoal of S-protein. J. ImmunoL 
124:1779-1783 
24.  Podack.  E. R., and  H. J.  Miiller-Eberhard.  1981.  Membrane  attack complex  of comple- 
ment:  evidence  for  its  dimeric  structure  based  on  hybrid  formation..L  BioL  Chem. 
25@3145-3148. 
25.  Singer, S  J., and G  L. Nicholson.  1972. The fluid mosaic model of the structure of ceti 
membranes.  Science (Wash.  D. C.).  175:720 731. 
26.  Thompson,  R.  A., and  P. J,  Lachmann.  t970.  Reactive lysis: the complement-mediated 
lysis of unsensitized cells. I. The characterization of the indicator factors and its identifi- 
cation as C7. J. Exp.  Mad  131:629~o43. 
27.  Tranum-Jensen,  J,,  S,  Bhakdi,  B.  Bhakdi-Lebnen,  O.  J.  Bjerrum.  and  V.  Speth.  1978. 
Complement lysis: the uitrastructure and orientation of the C5b-9 complex on target sheep 
erythrocyte  membranes.  Stand  J. lmmunoL  7:45-56. 
28,  Ware. C. G., and W. P. Kotb,  1981. Assembly of the functional membrane attack complex 
of human complement: lbrmation of disulfide-linked C9 dimers Proc  NatL Acad ScL  U. 
S.  A, 78:6426-6430. 
29  Ware, C.  F.,  R  A,  Wetsel, and  W.  P,  Kolb  1981.  Physicochemical  characterization of 
fluid-phase  (SC5b-9)  and  membrane  derived  {MC5b-9)  attack  complexes  of human 
complement purified by immunoadsorbent  affinity chromatography  or selective detergent 
extraction. MoL ImmunoL  18:521  531 